RASGRP3 and colorectal carcinoma: To determine whether RASGRP3 is essential for AC092894.1 to mediate oxaliplatin resistance in CRC cells, we knocked down RASGRP3 in LoVo-OxR (AC092894.1) and HCT116-OxR (AC092894.1) cells, respectively (Fig. 4A).